The concern of generic competition has long loomed over copyright’s blockbuster drug, Viagra, triggering questions about the future of related drug investments. While early times saw significant gains, the exclusivity expiration has opened the way for less expensive copies, possibly reducing revenue and presenting a genuine danger for shareholde… Read More